| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib. | Hepatol Res | 2014 | 0.88 |
| 2 | Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma. | Case Rep Oncol | 2012 | 0.79 |